Connexin 43‐targeted T1 contrast agent for MRI diagnosis of glioma

Contrast Media & Molecular Imaging

Natalia Nukolova¹  Alexander Kabanov²  Vladimir Chekhonin³  Sergey Shein³  Tatiana Abakumova³  Nadezhda Grinenko³  Gaukhar Yusubalieva³  Dmitry Bychkov⁴  Maxim Abakumov⁵  Vladimir Mukhin⁵  Pavel Chelushkin⁶ 

[1] Center for Nanotechnology in Drug Delivery and Division of Molecular Therapeutics, UNC Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill NC USA;Department of Chemistry, Laboratory Chemical Design of Bionanomaterials Lomonosov Moscow State University Moscow Russia;Department of Fundamental and Applied Neurobiology Serbsky National Research Center for Social and Forensic Psychiatry Moscow Russia;Department of Geology Lomonosov Moscow State University Moscow Russia;Department of Medical Nanobiotechnology Pirogov Russian National Research Medical University Moscow Russia;Laboratory of Synthesis of Peptides and Polymer Microspheres Institute of Macromolecular Compounds, Russian Academy of Sciences St Petersburg Russia

关键词: T1 contrast agent;    cellular targeting;    MRI;    targeted imaging;    connexin 43;    glioma;   

DOI  :  10.1002/cmmi.1653

学科分类：放射科、核医学、医学影像

来源: Hindawi Publishing Corporation

【 授权许可】

CC BY